Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Molecular Imaging
Radnostix to sell nuclear fuel processing assets for $13.5M
By
AuntMinnie.com staff writers
Assets include a U.S. Nuclear Regulatory Commission (NRC) license, patented technology, and related technical materials.
October 1, 2026
Eden selects Kiewit as partner for NM isotope facility
By
AuntMinnie.com staff writers
The project is expected to create 205 jobs and generate more than $1.5 billion in economic impact over 10 years.
September 28, 2026
USC researchers develop “plug-and-play" platform for PET tracers
By
Will Morton
Preliminary work suggests the approach can generate tracers targeting fibroblast activation protein.
September 24, 2026
Telix inks deal to acquire ITM for $1.65B
By
Erik L. Ridley
The deal would create a combined company with significant radioisotope manufacturing, distribution, and radiopharmaceutical development capabilities.
September 21, 2026
FES-PET guides second-line therapy decisions in breast cancer
By
Will Morton
FES-PET/CT results led to therapeutic management changes in 37.8% of patients.
September 18, 2026
MICSI secures FDA clearance for MR-guided PET platform
By
AuntMinnie.com staff writers
The platform is cleared across F-18 FDG, amyloid (florbetapir, florbetaben, flutemetamol), and tau (flortaucipir) radiotracers.
September 16, 2026
Curium gets FDA approval for Lu-177 injection for GEP-NETs
By
AuntMinnie.com staff writers
The radioligand therapy delivers targeted radiation to GEP-NETs by binding to somatostatin receptors expressed on these tumors.
September 15, 2026
CAIX-targeted PET tracer shows promise in patients with ccRCC
By
Will Morton
Ga-68 DPI-4452 PET/CT correctly identified all 23 primary clear cell renal cell carcinoma tumors, achieving 100% sensitivity.
September 14, 2026
FDA clears new PET agent for brain cancer imaging
By
AuntMinnie.com staff writers
Gliomas account for approximately 30% of all brain and central nervous system tumors.
September 14, 2026
Ratio Therapeutics, RayzeBio join forces
By
AuntMinnie.com staff writers
The firms will collaborate on a radiopharmaceutical program focused on two cancer targets.
September 9, 2026
Coalition launches Cardiac PET Alliance
By
AuntMinnie.com staff writers
The coalition represents more than 1,200 cardiologists across 101 cardiovascular group practices in 24 states.
September 9, 2026
Siemens expands PET detector manufacturing site
By
AuntMinnie.com staff writers
The project significantly increases production capacity at its East Tennessee Molecular Imaging Complex.
September 9, 2026
Page 1 of 635
Next Page